vs
Pediatrix Medical Group, Inc.（MD）とRevolve Group, Inc.（RVLV）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $324.4M、Revolve Group, Inc.の約1.5倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 5.7%、差は1.1%）。Revolve Group, Inc.の前年同期比売上増加率が高い（10.4% vs -1.7%）。過去8四半期でRevolve Group, Inc.の売上複合成長率が高い（9.5% vs -0.1%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
Revolve Theatre Companyはテムズ河畔ヘンリーを拠点とする劇団で、政治的なテーマの作品やシェイクスピア劇を専門に制作・上演しており、オリバー・デンチ、ジョー・モリス、トム・スミスの3人が所有しています。
MD vs RVLV — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $324.4M |
| 純利益 | $33.7M | $18.6M |
| 粗利率 | — | 53.3% |
| 営業利益率 | 9.9% | 6.3% |
| 純利益率 | 6.8% | 5.7% |
| 売上前年比 | -1.7% | 10.4% |
| 純利益前年比 | 10.5% | 50.4% |
| EPS（希薄化後） | $0.40 | $0.27 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $324.4M | ||
| Q3 25 | $492.9M | $295.6M | ||
| Q2 25 | $468.8M | $309.0M | ||
| Q1 25 | $458.4M | $296.7M | ||
| Q4 24 | $502.4M | $293.7M | ||
| Q3 24 | $511.2M | $283.1M | ||
| Q2 24 | $504.3M | $282.5M | ||
| Q1 24 | $495.1M | $270.6M |
| Q4 25 | $33.7M | $18.6M | ||
| Q3 25 | $71.7M | $21.2M | ||
| Q2 25 | $39.3M | $10.2M | ||
| Q1 25 | $20.7M | $11.8M | ||
| Q4 24 | $30.5M | $12.3M | ||
| Q3 24 | $19.4M | $11.0M | ||
| Q2 24 | $-153.0M | $15.4M | ||
| Q1 24 | $4.0M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | 9.9% | 6.3% | ||
| Q3 25 | 13.8% | 7.1% | ||
| Q2 25 | 12.8% | 5.8% | ||
| Q1 25 | 7.0% | 5.0% | ||
| Q4 24 | 7.8% | 3.9% | ||
| Q3 24 | 6.6% | 5.0% | ||
| Q2 24 | -31.3% | 5.8% | ||
| Q1 24 | 3.2% | 3.4% |
| Q4 25 | 6.8% | 5.7% | ||
| Q3 25 | 14.5% | 7.2% | ||
| Q2 25 | 8.4% | 3.3% | ||
| Q1 25 | 4.5% | 4.0% | ||
| Q4 24 | 6.1% | 4.2% | ||
| Q3 24 | 3.8% | 3.9% | ||
| Q2 24 | -30.3% | 5.4% | ||
| Q1 24 | 0.8% | 4.0% |
| Q4 25 | $0.40 | $0.27 | ||
| Q3 25 | $0.84 | $0.29 | ||
| Q2 25 | $0.46 | $0.14 | ||
| Q1 25 | $0.24 | $0.16 | ||
| Q4 24 | $0.37 | $0.18 | ||
| Q3 24 | $0.23 | $0.15 | ||
| Q2 24 | $-1.84 | $0.21 | ||
| Q1 24 | $0.05 | $0.15 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $292.3M |
| 総負債低いほど良い | $570.5M | — |
| 株主資本純資産 | $865.9M | $512.5M |
| 総資産 | $2.2B | $765.0M |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $292.3M | ||
| Q3 25 | $340.1M | $315.4M | ||
| Q2 25 | $224.7M | $310.7M | ||
| Q1 25 | $99.0M | $300.8M | ||
| Q4 24 | $229.9M | $256.6M | ||
| Q3 24 | $103.8M | $252.8M | ||
| Q2 24 | $19.4M | $244.7M | ||
| Q1 24 | $8.0M | $273.4M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $512.5M | ||
| Q3 25 | $890.7M | $490.2M | ||
| Q2 25 | $833.8M | $468.6M | ||
| Q1 25 | $789.2M | $453.4M | ||
| Q4 24 | $764.9M | $437.8M | ||
| Q3 24 | $732.5M | $420.8M | ||
| Q2 24 | $706.5M | $405.8M | ||
| Q1 24 | $856.2M | $389.9M |
| Q4 25 | $2.2B | $765.0M | ||
| Q3 25 | $2.2B | $751.3M | ||
| Q2 25 | $2.1B | $722.9M | ||
| Q1 25 | $2.0B | $713.9M | ||
| Q4 24 | $2.2B | $665.5M | ||
| Q3 24 | $2.1B | $670.9M | ||
| Q2 24 | $2.0B | $657.8M | ||
| Q1 24 | $2.2B | $650.0M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $-10.2M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $-13.3M |
| FCFマージンFCF / 売上 | — | -4.1% |
| 設備投資強度設備投資 / 売上 | — | 1.0% |
| キャッシュ転換率営業CF / 純利益 | 3.39× | -0.55× |
| 直近12ヶ月FCF直近4四半期 | — | $48.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $-10.2M | ||
| Q3 25 | $137.3M | $11.8M | ||
| Q2 25 | $137.2M | $12.6M | ||
| Q1 25 | $-117.5M | $45.1M | ||
| Q4 24 | $133.0M | $3.9M | ||
| Q3 24 | $91.8M | $9.1M | ||
| Q2 24 | $107.0M | $-24.7M | ||
| Q1 24 | $-125.2M | $38.4M |
| Q4 25 | — | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | — | $36.7M |
| Q4 25 | — | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 3.39× | -0.55× | ||
| Q3 25 | 1.91× | 0.56× | ||
| Q2 25 | 3.49× | 1.24× | ||
| Q1 25 | -5.66× | 3.82× | ||
| Q4 24 | 4.36× | 0.32× | ||
| Q3 24 | 4.72× | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | -31.03× | 3.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
